Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers V > Headlines for Vertex Pharmaceuticals Inc. > News item |
Vertex Pharmaceuticals registers stock in automatic shelf filing
By Laura Lutz
Des Moines, Sept. 11 - Vertex Pharmaceuticals Inc. filed an automatic shelf registration of common stock in an S-3ASR filing with the Securities and Exchange Commission.
The filing includes $24,337,500 previously registered but unsold securities.
Proceeds will be used for general corporate purposes.
Based in Cambridge, Mass., Vertex develops and commercializes small-molecule drugs for serious diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.